The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-Line, Non-Hormonal, Treatment of Women with HER2 Overexpressing Metastatic Breast Cancer with Herceptin (Trastuzumab, Humanized Anti-HER2 Antibody).
 
Alexandra G Lopez-Aguiar
No Relationships to Disclose
 
Lauren McLendon Postlewait
No Relationships to Disclose
 
Mohammad Zaidi
No Relationships to Disclose
 
Kristen Zhelnin
No Relationships to Disclose
 
Alyssa Krasinskas
No Relationships to Disclose
 
Maria C. Russell
No Relationships to Disclose
 
David A. Kooby
No Relationships to Disclose
 
Kenneth Cardona
No Relationships to Disclose
 
Bassel F. El-Rayes
Consulting or Advisory Role - BTG; Genentech/Roche; Merrimack; Merrimack
Research Funding - AVEO (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Cleave Biosciences (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Hoosier Cancer Research Network (Inst); Novartis (Inst); Pfizer (Inst); PPD (Inst); Taiho Pharmaceutical (Inst)
 
Shishir Maithel
No Relationships to Disclose